Michael Mainelli
2018
In 2018, Michael Mainelli earned a total compensation of $1.1M as Former Interim Chief Executive Officer at Xtant Medical Holdings.
Compensation breakdown
| Non-Equity Incentive Plan | $90,865 |
|---|---|
| Option Awards | $670,560 |
| Salary | $92,885 |
| Stock Awards | $153,331 |
| Other | $89,889 |
| Total | $1,097,530 |
Mainelli received $670.6K in option awards, accounting for 61% of the total pay in 2018.
Mainelli also received $90.9K in non-equity incentive plan, $92.9K in salary, $153.3K in stock awards and $89.9K in other compensation.
Rankings
In 2018, Michael Mainelli's compensation ranked 8,745th out of 14,244 executives tracked by ExecPay. In other words, Mainelli earned more than 38.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 8,745 out of 14,244 | 39th |
Division Manufacturing | 3,487 out of 5,765 | 40th |
Major group Chemicals And Allied Products | 1,321 out of 2,128 | 38th |
Industry group Drugs | 1,106 out of 1,817 | 39th |
Industry Biological Products, Except Diagnostic Substances | 210 out of 339 | 38th |
Source: SEC filing on September 20, 2019.
Mainelli's colleagues
We found three more compensation records of executives who worked with Michael Mainelli at Xtant Medical Holdings in 2018.